| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |